Corline Biomedical AB (publ) Stock: price and insider trades · Sweden
No insider purchase over the last 90 days. The latest, by Annika Sunnanväder, was filed 01 Feb 2021.
Corline Biomedical AB (publ): what insiders have been doing
Every trade that managers of Corline Biomedical AB (publ) disclose to Finansinspektionen is tracked on this page. No insider at Corline Biomedical AB (publ) has published a filing in the past twelve months. The most recent one dates from 1 February 2021.
The full history, which starts in 2020, counts 2 purchases against 2 sales.
Elsewhere in the same market, our signals recently picked up insider purchases at Dynavox Group AB and Rusta AB (publ). These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
- 1,253,717 shares@ SEK 0.4112100.0% of flowTeckningsrätt/UniträttISIN SE0015356936FI:csv-31d3396d43b7ccc386d6Canonical exit: 20 Apr 2021 (T+90)
- 854,614 shares@ SEK 0.40100.0% of flowTeckningsrätt/UniträttISIN SE0015356936FI:csv-b57d82c32a45bc2b987b
- 477,877 shares@ SEK 10.0099.6% of flowBTA (betald tecknad aktie)FI:csv-91271702e14064652f48Canonical exit: 22 Apr 2021 (T+90)
- 100,000 shares@ SEK 0.18100.0% of flowOptionFI:csv-38f2a0e5f6789d2cb7c1
4 of 4 declarations
About Corline Biomedical AB (publ)
Corline Biomedical AB (publ) is a Swedish company focused on the development of biopharmaceutical products. It is listed on the Stockholm Stock Exchange (XSTO).
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations